Expression and shedding of endothelial protein C receptor in prostate cancer cells

Cancer Cell International

Volumn 11, Issue , 2011, Pages

  Menschikowski, Mario ^a   Hagelgans, Albert ^a   Tiebel, Oliver ^a   Klinsmann, Ludwig ^a   Eisenhofer, Graeme ^a   Siegert, Gabriele ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINOPHENYLMERCURIC ACETATE; ACTIVATED PROTEIN C; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ENDOTHELIAL PROTEIN C RECEPTOR; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; IONOMYCIN; MESSENGER RNA; METALLOPROTEINASE; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN; CELL STRAIN LNCAP; CELL STRAIN PC3; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LIPID RAFT; MALE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 79851508105     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-11-4     Document Type: Article

References (34)

1. McDowell ME, Occhipinti S, Gardiner RA, Baade PD, Steginga SK. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. Eur J Cancer Care (Engl) 2009, 18:545-555. 10.1111/j.1365-2354.2008.01046.x, 19686273.
2. de la Fouchardière C, Flechon A, Droz JP. Coagulopathy in prostate cancer. Neth J Med 2003, 61:347-354.
3. Kohli M, Kaushal V, Mehta P. Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost 2003, 29:301-308. 10.1055/s-2003-40968, 12888934.
4. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983, 62:14-31.
5. Green KB, Silverstein RL. Hypercoagulability in cancer. Hematol Oncol Clin North Am 1996, 10:499-530. 10.1016/S0889-8588(05)70349-X, 8707766.
6. ten Cate H, Falanga A. Overview of the postulated mechanisms linking cancer and thrombosis. Pathophysiol Haemost Thromb 2008, 36:122-130. 10.1159/000175150, 19176985.
7. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004, 24:1374-1383. 10.1161/01.ATV.0000134298.25489.92, 15178554.
8. Castellino FJ, Ploplis VA. The protein C pathway and pathologic processes. J Thromb Haemost 2009, 7:140-145. 10.1111/j.1538-7836.2009.03410.x, 19630787.
9. Tsuneyoshi N, Fukudome K, Horiguchi S, Ye X, Matsuzaki M, Toi M, Suzuki K, Kimoto M. Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines. Thromb Haemost 2001, 85:356-361.
10. Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009, 23:225-229. 10.1016/j.blre.2009.07.002, 2762278, 19683659.
11. Esmon CT. The protein C pathway. Chest 2003, 124:26S-32S. 10.1378/chest.124.3_suppl.26S, 12970121.
12. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms of modulating inflammation and apoptosis. J Biol Chem 2001, 276:11199-11203. 10.1074/jbc.C100017200, 11278252.
13. Beaulieu LM, Church FC. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Exp Cell Res 2007, 313:677-687. 10.1016/j.yexcr.2006.11.019, 17254565.
14. Suzuki K, Hayashi T. Protein C and its inhibitor in malignancy. Semin Thromb Hemost 2007, 33:667-672. 10.1055/s-2007-991534, 18000793.
15. Bezuhly M, Cullen R, Esmon CT, Morris SF, West KA, Johnston B, Liwski RS. Role of activated protein C and its receptor in inhibition of tumor metastasis. Blood 2009, 113:3371-3374. 10.1182/blood-2008-05-159434, 19188668.
16. Van Sluis GL, Niers TM, Esmon CT, Tigchelaar W, Richel DJ, Buller HR, Van Noorden CJ, Spek CA. Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1 mediated vascular endothelial barrier enhancement. Blood 2009, 114:1968-1973. 10.1182/blood-2009-04-217679, 2738579, 19571314.
17. Scheffer GL, Flens MJ, Hageman S, Izquierdo MA, Shoemaker RH, Scheper RJ. Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells. Eur J Cancer 2002, 38:1535-1542. 10.1016/S0959-8049(02)00108-9, 12110501.
18. Wang X, Wang E, Kavanagh JJ, Freedman RS. Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 2005, 3:25-44. 10.1186/1479-5876-3-25, 1182397, 15969748.
19. Suzuki K, Hayashi T. Protein C and its inhibitor in malignancy. Semin Thromb Hemost 2007, 33:667-672. 10.1055/s-2007-991534, 18000793.
20. Gramling MW, Beaulieu LM, Church FC. Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction. Exp Cell Res 2010, 316:314-328. 10.1016/j.yexcr.2009.10.024, 2812600, 19891966.
21. Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB. Activation of cartilage matrix metalloproteinases by activated protein C. Arthritis Rheum 2009, 60:780-791. 10.1002/art.24303, 19248107.
22. Kobayashi H, Moniwa N, Gotoh J, Sugimura M, Terao T. Role of activated protein C in facilitating basement membrane invasion by tumor cells. Cancer Res 1994, 54:261-267.
23. Xu J, Qu D, Esmon NL, Esmon CT. Metalloproteolytic release of endothelial cell protein C receptor. J Biol Chem 2000, 275:6038-44. 10.1074/jbc.275.8.6038, 10681599.
24. Qu D, Wang Y, Esmon NL, Esmon CT. Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-α converting enzyme/ADAM17. J Thromb Haemost 2007, 5:395-402. 10.1111/j.1538-7836.2007.02347.x, 17155946.
25. Menschikowski M, Hagelgans A, Eisenhofer G, Siegert G. Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Exp Cell Res 2009, 315:2673-2682. 10.1016/j.yexcr.2009.05.015, 19467228.
26. Liaw PC, Neuenschwander PF, Smirnov MD, Esmon CT. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 2000, 275:5447-5452. 10.1074/jbc.275.8.5447, 10681521.
27. Li YC, Park MJ, Ye SK, Kim CW, Kim YN. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 2006, 168:1107-1118. 10.2353/ajpath.2006.050959, 1606567, 16565487.
28. Krycer JR, Kristiana I, Brown AJ. Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3. PLoS One 2009, 4:e8496. 10.1371/journal.pone.0008496, 2794383, 20041144.
29. Sharrard RM, Maitland NJ. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Cell Signal 2007, 19:129-138. 10.1016/j.cellsig.2006.05.029, 16842970.
30. Spiotto MT, Chung TD. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate 2000, 42:88-98. 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P, 10617865.
31. Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Interruption of nuclear factor κB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Res 2003, 63:7106-7112.
32. Mehdi MZ, Azar ZM, Srivastava AK. Role of receptor and nonreceptor protein tyrosine kinases in H2O2-induced PKB and ERK1/2 signaling. Cell Biochem Biophys 2007, 47:1-10.
33. Aalinkeel R, Nair MP, Sufrin G, Mahajan SD, Chadha KC, Chawda RP, Schwartz SA. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res 2004, 64:5311-5321. 10.1158/0008-5472.CAN-2506-2, 15289337.
34. White SJ, Simmonds RE, Lane DA, Baker AH. Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning. Peptides 2005, 26:1264-1269. 10.1016/j.peptides.2005.01.015, 15949645.